Nalaganje...
Cetuximab in non-small-cell lung cancer
Cetuximab is a chimeric monoclonal antibody that is directed towards the epidermal growth factor receptor (EGFR). It has been evaluated in combination with first-line chemotherapy in several phase II and two phase III trials in patients with advanced NSCLC. The phase III FLEX trial demonstrated impr...
Shranjeno v:
| izdano v: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Pioneer Bioscience Publishing Company
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4367590/ https://ncbi.nlm.nih.gov/pubmed/25806155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.11.01 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|